Drug Evaluation Committee Aim of the Medical Education Meeting
Medical Affairs Subcommittee
December 2022
The MA Subcommittee's Continuing Task Force 3 has been discussing the ideal format for academic seminars and symposia to be led by MAs since FY2020, and released "Q&A on the Implementation of Medical Education Meetings and Medical Booths" in July 2021.
Subsequently, the task force held further discussions and has now published "The Direction to Aim for Medical Education Meetings" as a product of the Drug Evaluation Committee.
At the same time, from the perspective of consistency in the deliverables of the MA Task Forces in FY2022 and unification of terminology definitions, we have also updated part of the "Q&A on the Implementation of Medical Education Meetings and Medical Booths" mentioned above.
We hope that this information will be helpful to our member companies when they review and improve their internal systems.
Japan Pharmaceutical Manufacturers Association, Committee on Drug Evaluation
MA Subcommittee 2022 Ongoing Task Force 3
Deliverables of the Drug Evaluation Committee Return to list of all deliverables